BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 28816089)

  • 1. Medusa's Head: The Complement System in Traumatic Brain and Spinal Cord Injury.
    Roselli F; Karasu E; Volpe C; Huber-Lang M
    J Neurotrauma; 2018 Jan; 35(2):226-240. PubMed ID: 28816089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory response in traumatic brain and spinal cord injury: The role of XCL1-XCR1 axis and T cells.
    Zhang M; Han X; Yan L; Fu Y; Kou H; Shang C; Wang J; Liu H; Jiang C; Wang J; Cheng T
    CNS Neurosci Ther; 2024 Jun; 30(6):e14781. PubMed ID: 38887195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identifying the Role of Complement in Triggering Neuroinflammation after Traumatic Brain Injury.
    Alawieh A; Langley EF; Weber S; Adkins D; Tomlinson S
    J Neurosci; 2018 Mar; 38(10):2519-2532. PubMed ID: 29437855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic complement dysregulation drives neuroinflammation after traumatic brain injury: a transcriptomic study.
    Toutonji A; Mandava M; Guglietta S; Tomlinson S
    Acta Neuropathol Commun; 2021 Jul; 9(1):126. PubMed ID: 34281628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The alternative and terminal pathways of complement mediate post-traumatic spinal cord inflammation and injury.
    Qiao F; Atkinson C; Kindy MS; Shunmugavel A; Morgan BP; Song H; Tomlinson S
    Am J Pathol; 2010 Dec; 177(6):3061-70. PubMed ID: 20952585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of early and terminal complement proteins associated with polymorphonuclear leukocytes in vitro and in vivo after spinal cord injury.
    Nguyen HX; Galvan MD; Anderson AJ
    J Neuroinflammation; 2008 Jun; 5():26. PubMed ID: 18578885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of complement pathways after contusion-induced spinal cord injury.
    Anderson AJ; Robert S; Huang W; Young W; Cotman CW
    J Neurotrauma; 2004 Dec; 21(12):1831-46. PubMed ID: 15684772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement plays an important role in spinal cord injury and represents a therapeutic target for improving recovery following trauma.
    Qiao F; Atkinson C; Song H; Pannu R; Singh I; Tomlinson S
    Am J Pathol; 2006 Sep; 169(3):1039-47. PubMed ID: 16936276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement Drives Synaptic Degeneration and Progressive Cognitive Decline in the Chronic Phase after Traumatic Brain Injury.
    Alawieh A; Chalhoub RM; Mallah K; Langley EF; York M; Broome H; Couch C; Adkins D; Tomlinson S
    J Neurosci; 2021 Feb; 41(8):1830-1843. PubMed ID: 33446516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement and spinal cord injury: traditional and non-traditional aspects of complement cascade function in the injured spinal cord microenvironment.
    Peterson SL; Anderson AJ
    Exp Neurol; 2014 Aug; 258():35-47. PubMed ID: 25017886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of C3 deficiency on inflammation and regeneration following spinal cord injury in mice.
    Guo Q; Li S; Liang Y; Zhang Y; Zhang J; Wen C; Lin S; Wang H; Su B
    Neurosci Lett; 2010 Nov; 485(1):32-6. PubMed ID: 20800648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the Role of CX3CL1 (Fractalkine) and Its Receptor CX3CR1 in Traumatic Brain and Spinal Cord Injury: Insight into Recent Advances in Actions of Neurochemokine Agents.
    Poniatowski ŁA; Wojdasiewicz P; Krawczyk M; Szukiewicz D; Gasik R; Kubaszewski Ł; Kurkowska-Jastrzębska I
    Mol Neurobiol; 2017 Apr; 54(3):2167-2188. PubMed ID: 26927660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural IgM antibodies that bind neoepitopes exposed as a result of spinal cord injury , drive secondary injury by activating complement.
    Narang A; Qiao F; Atkinson C; Zhu H; Yang X; Kulik L; Holers VM; Tomlinson S
    J Neuroinflammation; 2017 Jun; 14(1):120. PubMed ID: 28629465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroimmunological therapies for treating spinal cord injury: Evidence and future perspectives.
    Chio JCT; Xu KJ; Popovich P; David S; Fehlings MG
    Exp Neurol; 2021 Jul; 341():113704. PubMed ID: 33745920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of the complement system in traumatic brain injury: a review.
    Hammad A; Westacott L; Zaben M
    J Neuroinflammation; 2018 Jan; 15(1):24. PubMed ID: 29357880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement activation in the injured central nervous system: another dual-edged sword?
    Brennan FH; Anderson AJ; Taylor SM; Woodruff TM; Ruitenberg MJ
    J Neuroinflammation; 2012 Jun; 9():137. PubMed ID: 22721265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of complement inhibiting component of Ephedra sinica on immunological inflammation following acute spinal cord injury in rats].
    Li LM; Zhu Y
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2012 Oct; 32(10):1385-9. PubMed ID: 23163152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement in the Development of Post-Traumatic Epilepsy: Prospects for Drug Repurposing.
    Chen M; Edwards SR; Reutens DC
    J Neurotrauma; 2020 Mar; 37(5):692-705. PubMed ID: 32000582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tau Pathology Triggered by Spinal Cord Injury Can Play a Critical Role in the Neurotrauma Development.
    Nakhjiri E; Vafaee MS; Hojjati SMM; Shahabi P; Shahpasand K
    Mol Neurobiol; 2020 Nov; 57(11):4845-4855. PubMed ID: 32808121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammasome: Its role in traumatic brain and spinal cord injury.
    Mortezaee K; Khanlarkhani N; Beyer C; Zendedel A
    J Cell Physiol; 2018 Jul; 233(7):5160-5169. PubMed ID: 29150951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.